Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Equities
  • General
  • Markets
  • News
  • Tech

Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis

By Benzinga Neuro
April 19, 5:31 AM
The analysis screened S&P 500 stocks that show an inverse correlation to Nvidia over a month and year period, following Nvidia's stock falling into correction territory for the second time this month.

BF

Read More
2 minute read
  • Contracts
  • News

Scout Clean Energy Announces 12-Year Virtual Power Purchase Agreement With Zoetis Inc.

By Benzinga Newsdesk
April 18, 9:12 AM
Scout Clean Energy (Scout), a Colorado-based renewable energy developer-owner-operator, is pleased to announce they have signed a Virtual Power Purchase Agreement (VPPA) with Zoetis Inc. for a 50-megawatt (MW) portion of

ZTS

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor
April 12, 2:47 PM
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

ADIL

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Cats

By Vandana Singh
April 12, 11:30 AM
Zoetis' Solensia and Librela, pioneering arthritis treatments for pets. Despite recent concerns, Zoetis defends their safety record, emphasizing positive outcomes for millions of treated animals.

ZTS

Read More
2 minute read
  • Markets
  • Options

A Closer Look at Zoetis’s Options Market Dynamics

By Benzinga Insights
April 12, 10:18 AM
Deep-pocketed investors have adopted a bullish approach towards Zoetis (NYSE:ZTS), and it’s something market players shouldn’t ignore. Our…

ZTS

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

(ZTS) – Analyzing Zoetis’s Short Interest

By Benzinga Insights
April 10, 10:00 AM
Zoetis’s (NYSE:ZTS) short percent of float has fallen 4.88% since its last report. The company recently reported that…

ZTS

Read More
3 minute read
  • Analyst Ratings

Expert Outlook: Zoetis Through The Eyes Of 4 Analysts

By Benzinga Insights
April 2, 10:00 AM
Ratings for Zoetis (NYSE:ZTS) were provided by 4 analysts in the past three months, showcasing a mix of…

ZTS

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Largest Animal Health Firm Zoetis Hit With European Probe Over Possible Breach of Competition Rules Related To Dog Pain Medicine

By Vandana Singh
March 27, 2:26 PM
The European Commission launches probe into Zoetis over alleged market interference in dog pain medication launch. Focus on Zoetis' Librela monoclonal antibody for osteoarthritis pain relief in dogs raises antitrust concerns.

ZTS

Read More
3 minute read
  • Analyst Ratings

4 Analysts Have This To Say About Zoetis

By Benzinga Insights
February 20, 1:00 PM
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Zoetis (NYSE:ZTS)…

ZTS

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

(ZTS) – Analyzing Zoetis’s Short Interest

By Benzinga Insights
February 14, 3:15 PM
Zoetis’s (NYSE:ZTS) short percent of float has risen 6.67% since its last report. The company recently reported that…

ZTS

Posts pagination

Previous 1 2 3 … 9 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service